2. Spółki
  3. Raporty Spółek ESPI/EBI

Raporty Spółek ESPI/EBI

Notification for sale of treasury shares SOPHARMA AD (BG11SOSOBT18)

02-09-2026 11:03:23 | ESPI | 227/2026
oUNI-EN: Notification for sale of treasury shares

PAP
Data: 2026-09-02
Firma: SOPHARMA AD
oSpis tresci:
1. REPORT
2. ESAP METADATE
3. INFORMATION ABOUT THE ENTITY
4. SIGNATURE OF PERSONS REPRESENTING THE COMPANY

oSpis zalacznikow:
Znaleziono 1 załącznik
  • BGFSC_DATTAD_ESAPS_097900BGGW0000048796-00012_26.rar
    		•  Arkusz: REPORT

    Nazwa arkusza: REPORT


    POLISH FINANCIAL SUPERVISION AUTHORITY
    UNI - EN REPORT No 227 / 2026
    Date of issue: 2026-09-02
    Short name of the issuer
    SOPHARMA AD
    Subject
    Notification for sale of treasury shares
    Official market - legal basis
    Art. 56 ust. 1 pkt 2 Ustawy o ofercie - informacje bieżące i okresowe
    Unofficial market - legal basis
    Contents of the report:
    Sofia, Bulgaria, September 2, 2026 - According to the requirements of art. 17 of the Regulation _EU_ No 596/2014 of the European Parliament and of the Council, "Sopharma" AD _SFA: Bulgarian Stock Exchange, SPH: Warsaw Stock Exchange_ notifies that on September 1, 2026 the Company sold 752 500 _seven hundred fifty-two thousand five hundred_ treasury shares representing 0.14% of the share capital of the Company, at a total value of EUR 1 655 677.00 on the Bulgarian Stock Exchange, the average price per share was EUR 2.20.
    The total number of treasury shares after this transaction is 0.
    Annexes
    File Description
    BGFSC_DATTAD_ESAPS_097900BGGW0000048796-00012_26.rar Notification for sale of treasury shares

    Nazwa arkusza: ESAP METADATE


    Legal framework Type of information
    TRANSD Acquisition or disposal of an issuer's own shares
    RegulatoryData
    Collection Body PLKNF
    Unique data record identifier
    Type of submission New _to be used for new information_
    Voluntary information flag
    Date or period covered [Date or beginning of the period to which the information relates] 2026-09-01
    Date or period covered [Date or end of the period to which the information relates] 2026-09-01
    Personal data flag
    Macierzyste państwo członkowskie, w stosownych przypadkach PL
    DocumentReference
    Język, w którym przekazano informacje Oryginał _ORIG_ czy tłumaczenie _TRAN_ Numer referencyjny pliku danych
    PL ORIG
    SubmittingEntity
    Submitting entity LEI or Submitting entity name - natural person
    097900BGGW0000048796
    RelatedEntity/LegalPerson
    Entity LEI Size of the entity Industry sector_s_
    097900BGGW0000048796 Large undertaking _acc. NACE_: C

    Nazwa arkusza: INFORMATION ABOUT THE ENTITY


    SOPHARMA AD
    _fullname of the issuer_
    SOPHARMA AD Farmaceutyczny _far_
    _short name of the issuer_ _sector according to clasification
    of the WSE in Warsow_
    1220 Sofia
    _post code_ _city_
    IlienskoShosse 16
    _street_ _number_
    +359 2 813 42 00 +359 2 936 02 86
    _phone number_ _fax_
    _e-mail_ _web site_
    nd
    _NIP_ _REGON_

    Nazwa arkusza: SIGNATURE OF PERSONS REPRESENTING THE COMPANY


    SIGNATURE OF PERSONS REPRESENTING THE COMPANY
    Date Name Position / Function Signature
    2026-09-02 Ognian Ivanov Donev Executive Director


    Identyfikator raportu jjvuszwyf1
    Nazwa raportu UNI-EN
    Symbol raportu UNI-EN
    Nazwa emitenta SOPHARMA AD
    Symbol Emitenta SOPHARMA AD
    Tytul Notification for sale of treasury shares
    Sektor Farmaceutyczny (far)
    Kod 1220
    Miasto Sofia
    Ulica IlienskoShosse
    Nr 16
    Tel. +359 2 813 42 00
    Fax +359 2 936 02 86
    e-mail
    NIP nd
    REGON
    Data sporzadzenia 2026-09-02
    Rok biezacy 2026
    Numer 227
    adres www
    Serwis Ekonomiczny Polskiej Agencji Prasowej SA 2026 Copyright PAP SA - Wszelkie prawa zastrzezone.